Irish firm reformulates endometriosis drug without animal ingredients

Zero Animal Biotech partnered with Indian manufacturer Akums to produce a lactose‑free version of dienogest, replacing animal-derived ingredients with plant-based alternatives. The agreement includes formulation development and regulatory approvals, expanding access for vegan patients.

An Irish startup has signed a new partnership to create a version of an endometriosis medication that contains no animal ingredients. The agreement aims to remove lactose and other animal products from the drug while keeping the active medicine the same. Partnership Details Dublin-based Zero Animal Biotech signed a development and supply agreement with Akums Drugs & Pharmaceuticals. Akums is an Indian contract manufacturer. Under the agreement, Akums will develop the formulation by replacing animal-derived ingredients with plant-based ones and will manufacture the finished product. Zero Animal Biotech will handle the regulatory approvals needed to bring the drug to patients. The companies did not disclose financial terms or a launch date. Dienogest is an oral progestin prescribed for pelvic pain caused by endometriosis. The World Health Organization estimates that the condition affects around 10% of women of reproductive age worldwide. Zero Animal Biotech states that no animal-free version of dienogest is on the market today. Tablets currently use lactose from cow’s milk, and capsules use gelatin made from animal bones and skin. Because dienogest is already an approved medicine, Zero Animal Biotech is not developing a new active ingredient. The startup says its formulation will not need new animal testing. Registered in Ireland in January 2026, the company describes itself as a pre-commercial R&D company developing vegan versions of generic medicines, with dienogest as its first program. Zero Animal Biotech puts the global dienogest market at more than USD 2 billion. The company expects demand from vegans, people who are lactose intolerant, and those who avoid animal products for religious reasons. Founder Background Founder Sarit Hashkes is vegan, lives with endometriosis, and takes a lactose-based medicine for the condition every day. Hashkes said that taking a medicine to help deal with a problematic uterus while it hurts other beings with a uterus makes the founder a hypocrite. Hashkes is documenting the development process in a personal video series on YouTube and TikTok called Can I Stop Being a Hypocrite? Medicine Industry Context The Vegan Society launched its Make More Medicines Vegan campaign in 2017. The organisation estimates that around 75% of the most commonly prescribed medicines in the UK contain animal-derived ingredients, usually inactive ones such as lactose, gelatin and magnesium stearate. Animal-free alternatives have so far appeared mostly in over-the-counter products and ingredient supply. In 2022, German pharmaceutical company axunio’s Paraveganio became the first medicinal product registered with the Vegan Trademark. Ingredient supplier Roquette has introduced a pea-based alternative to gelatin softgel capsules. Patient demand affects whether people take their medication at all. A 2020 survey by ProVeg and the whatsinmymeds app found that 27% of 700 vegan respondents had refused a medication at least once because it was not vegan. Hashkes stated that the agreement is the first real step toward changing that, for the founder and for everyone else with endometriosis who does not want to hurt other sentient beings. Cultivated X added a concluding note thanking readers and asking them to confirm their newsletter subscription in an email.

Read source: Cultivated X